The atopic dermatitis market size is projected to grow from USD 13.69 billion in 2025 to USD 31.86 billion by 2035, representing a CAGR of 8.81% during the forecast period till 2035. According to an Oxford Academic report, nearly 2.6% of the population is affected by atopic dermatitis worldwide where children are more affected compared to adults,. This number exhibits a high prevalence of skin conditions similar to eczema that raise the atopic dermatitis market demand. Atopic dermatitis also kno...

The global thermoplastic elastomers market size is valued at USD 26.77 billion in 2024 and is poised to reach USD 47.25 billion by 2035, representing a higher CAGR of 5.30% during the forecast period. In November 2024, GEON Performance Solutions launched a new TPE manufacturing line in Mexico facility, in order to expand the production of thermoplastic elastomers and thermoplastic vulcanizate.

The bioreactors market size is estimated to grow from $16.7 billion currently to $51.7 billion by 2035, representing a CAGR of 11.1% during the forecast period, till 2035. The global expansion of biopharmaceutical products has led to significant growth in the bioprocessing supplies market. Over the past two decades, this market has consistently grown at an annual rate of between 12 and 14%. With companies either establishing their own biopharmaceutical manufacturing facilities or outsourcing pro...

The medical exoskeleton market, valued at USD 1.41 billion in 2025, is projected to grow to USD 1.79 billion in 2026 and USD 8.70 billion by 2035, representing a CAGR of 19.2% during the forecast period. Medical exoskeletons are wearable robotic devices designed to assist individuals with mobility impairments. They use a combination of mechanical, electronic, and computer-controlled systems to support and enhance the user's movement, typically targeting specific body parts affected by injury or...

The global myasthenia gravis market is estimated to grow from USD 1.61 billion in 2024 to USD 3.13 billion by 2035, representing a compounded annual growth rate (CAGR) of 6.20% during the forecast period. As per the report of the Myasthenia Gravis Foundation of America, over 70,000 people in US have been diagnosed with myasthenia gravis, indicating a significant increase in the number of patients. It is important to highlight here that since 2017, the USFDA has approved several monoclonal antibo...

Over the last two decades, medical researchers have been able to achieve proof-of-concept and demonstrate the viability of benefits of mRNA-based interventions. In fact, currently, there are more than 65 mRNA-based therapeutics and over 85 mRNA vaccines under development. In vitro transcribed mRNA is now being evaluated as a treatment option for several oncological and genetic disorders. Moreover, experts believe that the applications of this upcoming product class are potentially limitless.

The global digital twin in healthcare market, valued at USD 2.5 billion in 2025, is projected to reach USD 3.4 billion in 2026 and USD 33.4 billion by 2035, with a 28.8% CAGR during the forecast period 2026 to 2035. According to a recent study, healthcare executives anticipate a significant increase in investment from pharmaceutical players with over 65% increased investment expected in this domain in the next three years. Digital twins also find their application in accelerating the pace of...

The global veterinary ultrasound market is valued at USD 0.43 billion in 2024 and is poised to reach USD 0.73 billion by 2035, representing a CAGR of 4.96% during the forecast period.

The global 3D printed drugs market size is valued at USD 281.63 million in 2024 and is poised to reach at USD 605.09 million by 2035, representing a CAGR of 7.20% during the forecast period. In September 2024, the APL (Leading manufacturer of extemporaneous medicine) and CurifyLabs (Finnish Health Tech Company) forged a collaboration deal to increase the administration of medicines to children using advanced 3D printing technology. Examples of key players engaged in this domain (which have also...

The global oligonucleotide synthesis market, valued at USD 5.7 billion in 2025, is projected to reach USD 6.8 billion in 2026 and USD 13.5 billion by 2035, with a 7.9% CAGR during the forecast period 2026 to 2035. In terms of application area, the research and diagnostics segment holds the highest share (~60%) of the market. Based on the type of oligonucleotide synthesized, the antisense oligonucleotide segment holds the largest market share (more than 60%).  With respect to scale of operatio...

The global medical device market size is anticipated to increase from USD 528.88 billion in 2024 to reach USD 857.39 billion by 2035, growing at a CAGR of 4.49% during the forecast period. In November 2024, Boston Scientific acquired Axonics, a medical technology company focused on development of devices for the treatment of bowel and urinary dysfunction. As stated by Meghan Scanlon, Senior Vice President and President, Urology, Boston Scientific,

The global telehealth services market size is estimated to grow from USD 60.48 billion in 2024 to USD 784.95 billion by 2035, growing at a CAGR of 26.24% during the forecast period. According to the Centers for Disease Control and Prevention, approximately 129 million people in the United States suffer from at least one major chronic condition, such as cancer, heart disease, diabetes, obesity and hypertension. This high prevalence of chronic diseases is expected to continue during the upcoming y...

The oncology precision medicine market, valued at USD 166 billion in 2025, is project to reach USD 185 billion in 2026 and USD 364 billion by 2035, representing a CAGR of 7.8% during the forecast period 2026 to 2035. In terms of type of cancer targeted, the blood / hematologic cancer segment holds the highest share (~25%) of the market. Based on the type of molecule, the biologics segment holds the largest market share (nearly 60%). With respect to drug class, kinase inhibitor captures the highe...

The global microbiome manufacturing market size is estimated to grow from USD 40.6 million in 2024 to USD 186.7 million by 2035, representing a CAGR of 14.9% during the forecast period. It is worth highlighting that, in November 2022, the US Food and Drug Administration (FDA) approved the first microbiome-based therapy, RBX2660 (developed by Rebiotix) for the treatment of recurrent Clostridium difficile infection. Notably, in April 2023, SER-109, a microbiome-based first oral therapy developed b...

The global malaria diagnostics market size is valued at USD 0.85 billion in 2024 and is projected to reach USD 1.45 billion by 2035, representing a CAGR of 5.0% during the forecast period. As per the World Health Organization (WHO) report, in 2022, nearly 6,08,000 people died due to malaria and 249 million new cases were reported in 2022. Of these, 94% cases were identified in the African region. In order to mitigate the growing concern of malaria, WHO has recommended early parasite-based diagno...

The medical aesthetics market, valued at USD 37.6 billion in 2024, is project to reach USD 40.9 billion in 2025 and USD 102.3 billion by 2035, representing a CAGR of 9.6% during the forecast period 2025 to 2035. Based on the end user, the clinics / medical spas, dermatology centers / cosmetic centers segment holds the largest market share (nearly 50%) in 2025. With respect to gender, females capture the highest share (90%). North America captures majority of the market share. Notably, Asia-Pacif...

The cell line characterization and cell line development market, valued at USD 2.71 billion in 2025, is projected to grow to USD 3.14 billion in 2026 and USD 8.38 billion by 2035, representing a CAGR of 11.5% during the forecast period. Cell line development and cell line authentication is a cost-intensive and complex process that requires multidisciplinary expertise. In fact, considering their critical role in drug discovery and development, cell lines need to be appropriately tested and valida...

The global home healthcare market size is valued at USD 311.66 billion in 2024 and is projected to reach USD 719.31 billion by 2035, representing a CAGR of 7.90% during the forecast period. North America currently accounts for the highest share (51%) of the market. Currently, services occupy an 85% share of the market with products accounting for the rest. The global market for home healthcare will also be propelled by increasing patient preferences for remote care and technological advancements...

The global cold chain market for pharmaceuticals, valued at USD 6.6 billion in 2025, is projected to reach USD 6.9 billion in 2026 and USD 9.6 billion by 2035, with a 3.8% CAGR during the forecast period, 2026 to 2035. The pharma cold chain specifically addresses the requirements of freezing / cryogenic holding temperature for a wide variety of temperature sensitive pharmaceutical products, such as biologics, covid vaccines, human organs, and certain conventional pharmacological interventions, s...

The global rehabilitation robots market size is estimated to grow from USD 0.29 billion in 2024 to USD 1.33 billion by 2035, representing a CAGR of 15% during the forecast period. In 2024, the World Health Organization reported that more than 15 million people are living with spinal cord injuries and the majority of these causes are due to accidental falls, road accidents and trauma. This rising incidence of spinal cord injuries has underscored the demand for rehabilitation robots, specifically...